EUVIMEDEUVIMED entdecken
Crossref

Nuclear factor, erythroid 2 like 2 (NRF2)‐mediated disruption of iron homeostasis drives myocardial infarction progression

Deepthy Jayakumar iD, Kishore Kumar S Narasimhan iD, Navvi Chandrasekar, Abinayaa Rajkumar, Gokulprasanth Panchalingam, Varsha C Ravikumar, Kalaiselvi Periandavan iD

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Deepthy Jayakumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Dr. ALM Post Graduate Institute for Basic Medical Sciences, University of Madras, Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Myocardial Infarction, NF-E2-Related Factor 2, Iron. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Disruptions in iron homeostasis are a hallmark of myocardial infarction (MI). Recent studies have implicated NRF2, a key transcriptional regulator of antioxidant and detoxification genes, in the regulation of iron metabolism, particularly in murine models of hepatic iron overload. Emerging evidence suggests that the NRF2/hepcidin/ferroportin axis plays a central role in co‐ordinating cardiac iron and redox homeostasis. However, the underlying mechanisms remain poorly understood. Experimental Approach In this study, we investigated the role of NRF2 in vivo using isoprenaline‐induced MI and in vitro under cobalt chloride (CoCl₂)‐induced hypoxia in H9c2 cardiomyocytes. Key Results Our results show that MI activates NRF2 signalling through increased nuclear NRF2 levels and upregulation of its downstream targets, accompanied by elevated hepcidin expression without ferroportin1 (IREG1) changes, suggesting enhanced iron sequestration in myocardial tissue and cardiomyocytes. We observed that iron regulatory protein 1 (IRP1) was significantly down‐regulated while IRP2 was up‐regulated in isoprenaline‐treated myocardium and hypoxia‐exposed H9c2 cells. In vivo brusatol administration ameliorated isoprenaline‐induced cardiac remodelling, shown by reduced infarct size and ECG alterations. Transcriptomic analysis of MI rats with brusatol showed downregulation of pathways in cardiac remodelling, fibrosis, hypoxia, inflammation, iron/glutathione metabolism, necroptosis and ferroptosis. In H9c2 cardiomyocytes under hypoxic conditions, brusatol increased ferroportin1 expression, decreased hepcidin levels and reduced intracellular labile iron, inhibiting ferritinophagy and cardiomyocyte death. Conclusion Together, our findings uncover a novel regulatory role for NRF2 in myocardial iron metabolism under stress conditions, highlighting potential therapeutic avenues targeting the NRF2 pathway in MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionNF-E2-Related Factor 2IronAnimalsRatsMaleHomeostasisMyocytes, CardiacCell LineIsoproterenolHepcidinsDisease ProgressionRats, Sprague-DawleyFerroportinCobalt

Stichwörter der Autor:innen

NRF2ferroportin1hepcidinhypoxiairon metabolismmyocardial infarction

Substanzen

NF-E2-Related Factor 2IronIsoproterenolHepcidinsNfe2l2 protein, ratFerroportinCobalt

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Dr. ALM Post Graduate Institute for Basic Medical Sciences, University of Madras, Chennai, Tamil Nadu, India.
  • Department of Psychiatry and Behavioral Sciences, Texas A&M Health Sciences Center, Naresh K. Vashisht College of Medicine, Texas A&M University, College Station, Texas, USA.
  • Department of Pathology, Dr. ALM Post Graduate Institute for Basic Medical Sciences, University of Madras, Chennai, Tamil Nadu, India.

ORCID-Profile: Deepthy Jayakumar, Kishore Kumar S Narasimhan, Kalaiselvi Periandavan

Zitieren

APA

Jayakumar, D., S Narasimhan, K. K., Chandrasekar, N., Rajkumar, A., Panchalingam, G., Ravikumar, V. C., & Periandavan, K. (2026). Nuclear factor, erythroid 2 like 2 (NRF2)‐mediated disruption of iron homeostasis drives myocardial infarction progression. British Journal of Pharmacology. https://doi.org/10.1111/bph.70198

Vancouver

Jayakumar D, S Narasimhan KK, Chandrasekar N, Rajkumar A, Panchalingam G, Ravikumar VC, et al. Nuclear factor, erythroid 2 like 2 (NRF2)‐mediated disruption of iron homeostasis drives myocardial infarction progression. British Journal of Pharmacology. 2026. doi:10.1111/bph.70198

BibTeX
@article{Jayakumar2026,
  author = {Jayakumar, Deepthy and S Narasimhan, Kishore Kumar and Chandrasekar, Navvi and Rajkumar, Abinayaa and Panchalingam, Gokulprasanth and Ravikumar, Varsha C and Periandavan, Kalaiselvi},
  title = {Nuclear factor, erythroid 2 like 2 (NRF2)‐mediated disruption of iron homeostasis drives myocardial infarction progression},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70198}
}
Kostenlos starten →